COVID-19 Pandemic: SARS-CoV-2 Specific Vaccines and Challenges, Protection Via BCG Trained Immunity, and Clinical Trials

Overview

Journal Expert Rev Vaccines

Date 2021 Jun 3

PMID 34078215

Citations 21

Authors

Wenping Gong

Ashok Aspatwar

Shuyong Wang

Seppo Parkkila

Xueqiong Wu

Affiliations

Soon will be listed here.

Abstract

: The coronavirus disease 2019 (COVID-19) pandemic continues to spread worldwide and vaccination remains the most effective approach to control COVID-19. Currently, at least ten COVID-19 vaccines have been authorized under emergency authorization. However, these vaccines still face many challenges.: This study reviews the concept and mechanisms of trained immunity induced by the Bacille Calmette Guérin (BCG) vaccine and identifies questions that should be answered before the BCG vaccine could be used to combat COVID-19 pandemic. Moreover, we present for the first time the details of current BCG vaccine clinical trials, which are underway in various countries, to assess its effectiveness in combating the COVID-19 pandemic. Finally, we discuss the challenges of COVID-19 vaccines and opportunities for the BCG vaccine. The literature was found by searching the PubMed (https://pubmed.ncbi.nlm.nih.gov/), Web of Science (www.webofknowledge.com), Embase (https://www.embase.com), and CNKI (https://www.cnki.net/) databases. The date was set as the default parameter for each database.: The advantages of the BCG vaccine can compensate for the shortcomings of other COVID-19 vaccines. If the efficacy of the BCG vaccine against COVID-19 is confirmed by these clinical trials, the BCG vaccine may be essential to resolve the challenges faced by COVID-19 vaccines.

Citing Articles

BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.

Noe A, Dang T, Axelrad C, Burrell E, Germano S, Elia S Front Immunol. 2023; 14:1242380.

PMID: 37691937 PMC: 10485613. DOI: 10.3389/fimmu.2023.1242380.

Next-Generation TB Vaccines: Progress, Challenges, and Prospects.

Zhuang L, Ye Z, Li L, Yang L, Gong W Vaccines (Basel). 2023; 11(8).

PMID: 37631874 PMC: 10457792. DOI: 10.3390/vaccines11081304.

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.

Du J, Su Y, Wang R, Dong E, Cao Y, Zhao W Front Immunol. 2023; 14:1118378.

PMID: 36798128 PMC: 9927227. DOI: 10.3389/fimmu.2023.1118378.

Efficacy of BCG Vaccination against COVID-19: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Wen J, Liu Q, Tang D, He J J Clin Med. 2023; 12(3).

PMID: 36769802 PMC: 9917948. DOI: 10.3390/jcm12031154.

Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of and SARS-CoV-2.

Peng C, Tang F, Wang J, Cheng P, Wang L, Gong W J Pers Med. 2023; 13(1).

PMID: 36675777 PMC: 9863242. DOI: 10.3390/jpm13010116.

References

Netea M, Giamarellos-Bourboulis E, Dominguez-Andres J, Curtis N, van Crevel R, van de Veerdonk F . Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell. 2020; 181(5):969-977. PMC: 7196902. DOI: 10.1016/j.cell.2020.04.042. View

Yi S, Kim Y, Choe Y, Ahn S, Han S, Park Y . Geospatial Analysis of Age-specific SARS-CoV-2 Transmission Patterns in Households, Korea. J Korean Med Sci. 2021; 36(8):e63. PMC: 7921369. DOI: 10.3346/jkms.2021.36.e63. View

Dai D, Wu X, Si F . Complexity analysis of cold chain transportation in a vaccine supply chain considering activity inspection and time-delay. Adv Differ Equ. 2021; 2021(1):39. PMC: 7794647. DOI: 10.1186/s13662-020-03173-z. View

Covian C, Retamal-Diaz A, Bueno S, Kalergis A . Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?. Front Immunol. 2020; 11:970. PMC: 7227382. DOI: 10.3389/fimmu.2020.00970. View

Gong W, Wu X . Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?. Indian J Tuberc. 2021; 68(3):401-404. PMC: 7641523. DOI: 10.1016/j.ijtb.2020.10.012. View

Ricke D . Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Front Immunol. 2021; 12:640093. PMC: 7943455. DOI: 10.3389/fimmu.2021.640093. View

Yamoah P, Bangalee V, Oosthuizen F . A review of the safety of vaccines used in routine immunization in Africa. Afr Health Sci. 2021; 20(1):227-237. PMC: 7750064. DOI: 10.4314/ahs.v20i1.28. View

Zhang L, Jackson C, Mou H, Ojha A, Peng H, Quinlan B . SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020; 11(1):6013. PMC: 7693302. DOI: 10.1038/s41467-020-19808-4. View

Rammohan A, Rela M . COVID-19: Could India still escape?. J Glob Health. 2020; 10(1):010372. PMC: 7307799. DOI: 10.7189/jogh.10.010372. View

10.

Arts R, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R . Immunometabolic Pathways in BCG-Induced Trained Immunity. Cell Rep. 2016; 17(10):2562-2571. PMC: 5177620. DOI: 10.1016/j.celrep.2016.11.011. View

11.

Gong W, Liang Y, Wu X . The current status, challenges, and future developments of new tuberculosis vaccines. Hum Vaccin Immunother. 2018; 14(7):1697-1716. PMC: 6067889. DOI: 10.1080/21645515.2018.1458806. View

12.

Aspatwar A, Gong W, Wang S, Wu X, Parkkila S . Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic. Int Rev Immunol. 2021; 41(2):283-296. PMC: 8108189. DOI: 10.1080/08830185.2021.1922685. View

13.

. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Rev Vaccines. 2009; 8(6):705-16. DOI: 10.1586/erv.09.40. View

14.

Fletcher H . Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine. mBio. 2016; 7(4). PMC: 4999557. DOI: 10.1128/mBio.01370-16. View

15.

Cirovic B, de Bree L, Groh L, Blok B, Chan J, van der Velden W . BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment. Cell Host Microbe. 2020; 28(2):322-334.e5. PMC: 7295478. DOI: 10.1016/j.chom.2020.05.014. View

16.

Arts R, Moorlag S, Novakovic B, Li Y, Wang S, Oosting M . BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018; 23(1):89-100.e5. DOI: 10.1016/j.chom.2017.12.010. View

17.

Chimoyi L, Velen K, Churchyard G, Wallis R, Lewis J, Charalambous S . An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19. PLoS One. 2020; 15(12):e0243707. PMC: 7746266. DOI: 10.1371/journal.pone.0243707. View

18.

The Lancet . India under COVID-19 lockdown. Lancet. 2020; 395(10233):1315. PMC: 7180023. DOI: 10.1016/S0140-6736(20)30938-7. View

19.

Song W, Colonna M . Immune Training Unlocks Innate Potential. Cell. 2018; 172(1-2):3-5. DOI: 10.1016/j.cell.2017.12.034. View

20.

Prabowo S, Painter H, Zelmer A, Smith S, Seifert K, Amat M . RUTI Vaccination Enhances Inhibition of Mycobacterial Growth and Induces a Shift of Monocyte Phenotype in Mice. Front Immunol. 2019; 10:894. PMC: 6503078. DOI: 10.3389/fimmu.2019.00894. View